Xcopri (cenobamate)

pCPA File Number: 22466

Negotiation Status:

Concluded without agreement

Indication(s):

Epilepsy, partial-onset seizures

Sponsor/Manufacturer:

Paladin Labs Inc.

CDA-AMC Project Number:

SR0770-000

pCPA Engagement Letter Issued:

2023-12-22

Negotiation Process Concluded:

2024-10-04